Your browser doesn't support javascript.
loading
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.
Steichen, Jon M; Lin, Ying-Cing; Havenar-Daughton, Colin; Pecetta, Simone; Ozorowski, Gabriel; Willis, Jordan R; Toy, Laura; Sok, Devin; Liguori, Alessia; Kratochvil, Sven; Torres, Jonathan L; Kalyuzhniy, Oleksandr; Melzi, Eleonora; Kulp, Daniel W; Raemisch, Sebastian; Hu, Xiaozhen; Bernard, Steffen M; Georgeson, Erik; Phelps, Nicole; Adachi, Yumiko; Kubitz, Michael; Landais, Elise; Umotoy, Jeffrey; Robinson, Amanda; Briney, Bryan; Wilson, Ian A; Burton, Dennis R; Ward, Andrew B; Crotty, Shane; Batista, Facundo D; Schief, William R.
Afiliación
  • Steichen JM; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Lin YC; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Havenar-Daughton C; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Pecetta S; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.
  • Ozorowski G; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Willis JR; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • Toy L; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.
  • Sok D; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Liguori A; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Kratochvil S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Torres JL; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Kalyuzhniy O; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Melzi E; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Kulp DW; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Raemisch S; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
  • Hu X; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Bernard SM; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Georgeson E; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Phelps N; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Adachi Y; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Kubitz M; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Landais E; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.
  • Umotoy J; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Robinson A; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Briney B; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Wilson IA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Burton DR; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Ward AB; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Crotty S; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.
  • Batista FD; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Schief WR; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Science ; 366(6470)2019 12 06.
Article en En | MEDLINE | ID: mdl-31672916
ABSTRACT
Vaccine induction of broadly neutralizing antibodies (bnAbs) to HIV remains a major challenge. Germline-targeting immunogens hold promise for initiating the induction of certain bnAb classes; yet for most bnAbs, a strong dependence on antibody heavy chain complementarity-determining region 3 (HCDR3) is a major barrier. Exploiting ultradeep human antibody sequencing data, we identified a diverse set of potential antibody precursors for a bnAb with dominant HCDR3 contacts. We then developed HIV envelope trimer-based immunogens that primed responses from rare bnAb-precursor B cells in a mouse model and bound a range of potential bnAb-precursor human naïve B cells in ex vivo screens. Our repertoire-guided germline-targeting approach provides a framework for priming the induction of many HIV bnAbs and could be applied to most HCDR3-dominant antibodies from other pathogens.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Vacunas contra el SIDA / Evolución Molecular Dirigida / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Inmunogenicidad Vacunal / Anticuerpos ampliamente neutralizantes Límite: Animals / Humans Idioma: En Revista: Science Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Vacunas contra el SIDA / Evolución Molecular Dirigida / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Inmunogenicidad Vacunal / Anticuerpos ampliamente neutralizantes Límite: Animals / Humans Idioma: En Revista: Science Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos